Showing results (581-590 of 816) with videos related to
Sort By:
Pageof 82
Blood|May 1, 1982
Low serum thymic hormone levels in patients with chronic graft-versus-host diseaseK Atkinson, G S Incefy, R Storb, et al.Bone Marrow Transplantation|July 31, 2007
Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disordersL M Burroughs, R Storb, W M Leisenring, et al.Experimental Hematology|September 1, 1989
Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factorF G Schuening, R Storb, S Goehle, et al.Bone Marrow Transplantation|December 2, 2000
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicitiesT Furlong, R Storb, C Anasetti, et al.Bone Marrow Transplantation|January 1, 1988
Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantationJ E Sanders, C D Buckner, R A Clift, et al.Experimental Hematology|March 1, 1976
Recovery from aplastic anemia following attempted marrow transplantationE D Thomas, R Storb, E R Giblett, et al.Bone Marrow Transplantation|January 25, 2007
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantationA Safdar, G Rodriguez, K V I Rolston, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1996
Community respiratory virus infections among hospitalized adult bone marrow transplant recipientsE Whimbey, R E Champlin, R B Couch, et al.Blood|October 1, 1993
Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factorC H Weaver, C D Buckner, K Longin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host diseaseF Carnevale-Schianca, P Martin, K Sullivan, et al.Pageof 82